Dysregulation of Whole-body Metabolism in Ovarian Cancer: A Longitudinal Study
Recruiting now
Conditions studied: Ovary Cancer
In brief
Minimal information is available regarding changes in whole-body metabolism in ovarian cancer patients, and no study has assessed whole-body lipid metabolism in this patient population. In this pilot study we will assess fasting and postprandial lipid metabolism of ovarian cancer patients before, during, and after treatment via indirect calorimetry.
Key facts
- Study ID
- NCT06800105
- Run by
- University of Tennessee Graduate School of Medicine
- People needed
- 10
- Starts
- 2023-03-22
- Expected to finish
- 2028-03-31
- Last updated by the study team
- 2025-01-29
Who can join
Age: 18 and older. Sex: female. Healthy volunteers: not accepted.
You may qualify if…
- Women
- Age >18
- Presumed ovarian cancer diagnosis (i.e. those being clinically evaluated for suspicion of ovary cancer)
- Planned treatment course for ovarian cancer involving cytoreductive surgery followed by chemotherapy
- Availability to commit to attending all study visits
- Internet access and consistent access to phone/email/text communication
You may not qualify if…
- Pregnancy
- Inability to provide voluntary informed consent
- Inability to consume the pre-study visit meal/snack and/or the study visit meal due to strict dietary restrictions
- Illicit substance use (e.g. cocaine, methamphetamines, heroin, street drugs) - marijuana and CBD oil and related supplements will be considered on a case-by-case basis by the principal investigators
- Circumstances and/or medical condition that would limit compliance with study requirements and protocol, as determined by the principal investigators
Where it is running
- University of Tennessee Graduate School of Medicine — Knoxville, Tennessee, United States (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.